Thomas Bartrum Sells 15,000 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA – Get Rating) EVP Thomas Bartrum sold 15,000 shares of the stock in a transaction dated Friday, March 3rd. The stock was sold at an average price of $28.55, for a total transaction of $428,250.00. Following the sale, the executive vice president now directly owns 91,355 shares in the company, valued at approximately $2,608,185.25. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Thomas Bartrum also recently made the following trade(s):

• On Friday, February 3rd, Thomas Bartrum sold 15,000 shares of Privia Health Group stock. The shares were sold at an average price of $26.56, for a total transaction of $398,400.00.
• On Thursday, January 12th, Thomas Bartrum sold 15,000 shares of Privia Health Group stock. The shares were sold at an average price of $25.39, for a total transaction of $380,850.00.

Privia Health Group Stock Performance

Shares of PRVA stock opened at $28.34 on Thursday. The company’s 50 day moving average price is $25.98 and its two-hundred day moving average price is $29.51. Privia Health Group, Inc. has a 52 week low of $17.99 and a 52 week high of $44.64.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on PRVA shares. The Goldman Sachs Group started coverage on shares of Privia Health Group in a research note on Friday, February 3rd. They issued a “buy” rating and a $32.00 target price on the stock. Stifel Nicolaus started coverage on shares of Privia Health Group in a research note on Thursday, December 8th. They issued a “buy” rating and a $28.00 target price on the stock. UBS Group started coverage on shares of Privia Health Group in a research note on Thursday, December 8th. They issued a “buy” rating and a $30.00 target price on the stock. Truist Financial reduced their target price on shares of Privia Health Group to $41.00 in a research note on Thursday, November 17th. Finally, SVB Leerink cut their price target on shares of Privia Health Group from $46.00 to $39.00 and set an “outperform” rating on the stock in a research report on Friday, November 11th. Thirteen investment analysts have rated the stock with a buy rating, According to MarketBeat.com, Privia Health Group presently has an average rating of “Buy” and a consensus target price of $38.93.

Institutional Trading of Privia Health Group

Several hedge funds have recently bought and sold shares of PRVA. Signaturefd LLC acquired a new stake in Privia Health Group during the 3rd quarter worth approximately $32,000. Assetmark Inc. raised its holdings in Privia Health Group by 35.2% during the 3rd quarter. Assetmark Inc. now owns 1,207 shares of the company’s stock worth $41,000 after buying an additional 314 shares during the period. Focused Wealth Management Inc acquired a new stake in Privia Health Group during the 4th quarter worth approximately $41,000. Nisa Investment Advisors LLC acquired a new stake in Privia Health Group during the 2nd quarter worth approximately $46,000. Finally, Point72 Hong Kong Ltd acquired a new stake in Privia Health Group during the 1st quarter worth approximately $47,000. 66.83% of the stock is currently owned by institutional investors and hedge funds.

About Privia Health Group

(Get Rating)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.